22 January 2015 - Deborah Wilkes
Archived
HRA Pharma said its emergency contraceptive EllaOne (ulipristal acetate) would be available without a prescription in some European countries from February 2015, following the European Commission's authorisation of the switch from prescription to non-prescription status throughout the European Union. The switch is proving controversial in a small number of countries, including Poland, but HRA said that it aimed to have "constructive" discussions with authorities to enable EllaOne to be "made available OTC in all countries".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.